Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18-45 years

Active surveillance of hepatitis E: a 10-year epidemiological analysis in a city in eastern China

Immunogenicity and safety of an<i> ORF7</i>-deficient skin- attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2atrial

Progress and Challenges to Hepatitis E Vaccine Development and Deployment

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Head-to-head immunogenicity comparison of an<i> Escherichia</i> coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial

JMJD2D stabilises and cooperates with HBx protein to promote HBV transcription and replication

The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study

Reconsideration of Maternal Serological Testing for Predicting Congenital CMV Infection

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters

Safety and immunogenicity of an<i> Escherichia</i> coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial

Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial

A topical platelet-independent multilevel clotting initiator for intraoperative hemostasis

Immunogenicity and safety of an<i> Escherichia</i> coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial

The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine

Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

The duration and breadth of antibody responses to 3-dose of inactivated COVID-19 vaccinations in healthy blood donors: An observational study

Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient

Prognosis of hepatitis E infection in patients with chronic liver disease: A meta-analysis

Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials

Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial

Comparison of HPV neutralizing and IgG antibodies in unvaccinated female adolescents

Long-Term immunopersistence and safety of the Escherichia coli-produced HPV-16/18 bivalent vaccine in Chinese adolescent girls

Risk of hepatocellular carcinoma in antiviral treatment-naive chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

Pre-existing maternal IgG antibodies as a protective factor against congenital cytomegalovirus infection: A mother-child prospective cohort study

Protection Duration of COVID-19 Vaccines: Waning Effectiveness and Future Perspective

Development of a skin- and neuro-attenuated live vaccine for varicella

The Risk of Transfusion-Transmitted Hepatitis E Virus: Evidence from Seroprevalence Screening of Blood Donations

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2

Serological Evidence of Hepatitis E Virus (HEV) Infection Among Ruminant Farmworkers: A Retrospective Study from Malaysia

Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal

Elimination of human cytomegalovirus DNA degradation in urine

Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study

Comparison of detection strategies for screening and confirming congenital cytomegalovirus infection in newborns in a highly seroprevalent population: a mother-child cohort study

Maternal CMV seroprevalence rate in early gestation and congenital cytomegalovirus infection in a Chinese population

Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response

Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

Sequential Acquisition of Human Papillomavirus Infection at Genital and Anal Sites, Liuzhou, China

Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages

Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18-45 years enrolled in a clinical trial

Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial

Immunogenicity of anEscherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals

The study of seroprevalence of hepatitis E virus and an investigation into the lifestyle behaviours of the aborigines in Malaysia

Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women

Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial

Sex Differences in the Incidence and Clearance of Anogenital Human Papillomavirus Infection in Liuzhou, China: An Observational Cohort Study

Prevalence, Concordance, and Transmission of Human Papillomavirus Infection Among Heterosexual Couples in Liuzhou, China: An Observational Perspective Study

Immunogenicity and safety of an accelerated hepatitis E vaccination schedule in healthy adults: a randomized, controlled, open-label, phase IV trial

Sex differences in the incidence and clearance of anal human papillomavirus infection among heterosexual men and women in Liuzhou, China: An observational cohort study

Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis

Risk factors associated with the vertical transmission of cytomegalovirus in seropositive pregnant women

Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China

Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A

Knowledge and Attitudes Regarding HPV and Vaccination Among Chinese Women Aged 20 to 35 Years in Fujian Province: A Cross-Sectional Study

Knowledge gaps and research priorities in the prevention and control of hepatitis E virus infection

Cytomegalovirus Shedding in Healthy Seropositive Female College Students: A 6-Month Longitudinal Study

The prevalence and concordance of human papillomavirus infection in different anogenital sites among men and women in Liuzhou, China: A population-based study

Incidence of anogenital warts in Liuzhou, south China: a comparison of data from a prospective study and from the national surveillance system

RISK FACTORS FOR ANTIBODY LOSS AFTER HEPATITIS E VIRUS NATURAL INFECTION OR VACCINATION: RESULTS OF A MULTI-SITE COHORT STUDY

Classification of human and zoonotic group hepatitis E virus (HEV) using antigen detection

Characterization of an Escherichia coil-derived human papillomavirus type 16 and 18 bivalent vaccine

Persistence of antibodies acquired by natural hepatitis E virus infection and effects of vaccination

Human papillomavirus prevalence and associated factors in women and men in south China: a population-based study

Prophylaxis against hepatitis E: at risk populations and human vaccines

Modeling the long-term antibody response of a hepatitis E vaccine

Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial

Regulator of G-Protein Signaling 19 (RGS19) and Its Partner G alpha-Inhibiting Activity Polypeptide 3 (GNAI3) Are Required for zVAD-Induced Autophagy and Cell Death in L929 Cells

Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination

Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine An open-label phase I clinical trial

Epidemiology of Zoonotic Hepatitis E: A Community-Based Surveillance Study in a Rural Population in China

Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy

Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults

Development of the Hepatitis E Vaccine: From Bench to Field

Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity

Safety of the hepatitis E vaccine for pregnant women: A preliminary analysis

Profile of Acute Infectious Markers in Sporadic Hepatitis E

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

Cellular Uptake Mechanism of Molecular Umbrella

Prediction of a common neutralizing epitope of H5N1 avian influenza virus by in silico molecular docking

Putative receptor-binding sites of hepatitis E virus

Specific Cellular Immune Response in Hepatitis E Patients

Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity

Immune response induced by a different combined immunization of HBsAg vaccine

Identification of a dominant H-2d restricted Th epitope on capsid protein of hepatitis E virus

Hydrophobicity of reactive site loop of SCCA1 affects its binding to hepatitis B virus